Home Research Research themes Universal health coverage Protocols 2001011

2001011

A prospective, randomized, partially-blinded, placebo-controlled, Phase-III, multicentre trial to asses safety, tolerability and immunogenicity of liquid influenza virus vaccine, trivalent, types A & B, live cold adapted (liquid CAIV-T) administered concomitantly with live attenuated, poliovirus vaccine in healthy children.
Short Title CAIV-T P511
Protocol No 2001011
Status Completed
Keywords VACCINE, INFLUENZA, COLD ADEPTED, ORAL POLIO VACCINE
Center Health Systems & Infectious Diseases
MDG(s) this protocol relates to
HPNSDP(s) this protocol relates to
PI Name Robert Fedric Breiman
Collaborating Institutes (169) Wyeth-Lederle Vaccines, USA
Funding
Summary
‹ Search All Protocols Here